Accessibility navigation


Development and investigation of mucoadhesive polymers based on chitosan for intravesical therapy

Kaldybekov, D. B., Shatabayeva, E. O., Polatkhan, A. A., Tuleyeva, R. N., Irmukhametova, G. S. and Khutoryanskiy, V. V. ORCID: https://orcid.org/0000-0002-7221-2630 (2024) Development and investigation of mucoadhesive polymers based on chitosan for intravesical therapy. Eurasian Journal of Chemistry. ISSN 2959-0671 (In Press)

[img] Text - Published Version
· Restricted to Repository staff only
· The Copyright of this document has not been checked yet. This may affect its availability.
· Available under License Creative Commons Attribution.

1MB

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.31489/2959-0663/4-24-2

Abstract/Summary

Intravesical drug delivery (IDD) refers to the administration of therapeutic agents directly into the urinary bladder through a catheter. Low permeability of the urinary bladder epithelium, poor retention of the thera-peutic agents due to dilution and periodic urine voiding as well as frequent catheterizations (with potential risk of infections) are the major limitations of IDD used in the treatment of bladder-related disorders, such as bladder cancer. In this work, the mucoadhesive properties of polymeric materials based on chitosan, chitosan-gellan gum, and chitosan-Carbopol™ 940 containing sodium fluorescein (NaFI) were investigated for their potential application in intravesical drug delivery. The evaluation of mucoadhesive properties was carried out using an in vitro flow-through method with fluorescent detection that simulates the interaction conditions of polymers with the urinary bladder mucosa. Additionally, the release kinetics of NaFI from polymer composi-tions under conditions mimicking the physiological environment of the bladder was studied using a fluores-cence spectrometry. The acquired data confirm the promise of using chitosan-based mucoadhesive polymers in developing systems for intravesical drug delivery, which could significantly enhance the efficacy of IDD therapy to treat urinary bladder-related disorders.

Item Type:Article
Refereed:Yes
Divisions:Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Pharmaceutics Research Group
ID Code:119619
Publisher:Karagandy University of the name of academician E.A. Buketov, Karaganda, Kazakhstan.

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation